Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(32:0) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 21.4 | pmol/sample |
| - | PE(32:0) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 41 | pmol/sample |
| - | PE(32:0) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 40.9 | pmol/sample |
| - | PE(32:0) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 27 | pmol/sample |
| - | PE(32:0) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 24.5 | pmol/sample |
| - | PE(32:0) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 12.8 | pmol/sample |
| - | PE(32:0) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 14 | pmol/sample |
| - | PE(32:0) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 16 | pmol/sample |
| - | PE(32:0) | C | 0.0 | BCD100427B001 | 33.8 | pmol/sample |
| - | PE(32:0) | C | 0.5 | BCD100427B003 | 19.1 | pmol/sample |
| - | PE(32:0) | C | 1.0 | BCD100427B007 | 52.5 | pmol/sample |
| - | PE(32:0) | C | 2.0 | BCD100427B011 | 22.5 | pmol/sample |
| - | PE(32:0) | C | 4.0 | BCD100427B015 | 27.2 | pmol/sample |
| - | PE(32:0) | C | 8.0 | BCD100427B019 | 18.1 | pmol/sample |
| - | PE(32:0) | C | 12.0 | BCD100427B023 | 11.9 | pmol/sample |
| - | PE(32:0) | C | 24.0 | BCD100427B027 | 19.3 | pmol/sample |
| - | PE(32:0) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 21.4 | pmol/sample |
| - | PE(32:0) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 25.8 | pmol/sample |
| - | PE(32:0) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 26.7 | pmol/sample |
| - | PE(32:0) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 23 | pmol/sample |
| - | PE(32:0) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 12.2 | pmol/sample |
| - | PE(32:0) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 8.94 | pmol/sample |
| - | PE(32:0) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 17.5 | pmol/sample |
| - | PE(32:0) | 25OH-Chol | 0.5 | BCD100427B004 | 42.4 | pmol/sample |
| - | PE(32:0) | 25OH-Chol | 1.0 | BCD100427B008 | 23 | pmol/sample |
| - | PE(32:0) | 25OH-Chol | 2.0 | BCD100427B012 | 50.6 | pmol/sample |
| - | PE(32:0) | 25OH-Chol | 4.0 | BCD100427B016 | 26.9 | pmol/sample |
| - | PE(32:0) | 25OH-Chol | 8.0 | BCD100427B020 | 18.5 | pmol/sample |
| - | PE(32:0) | 25OH-Chol | 12.0 | BCD100427B024 | 12 | pmol/sample |
| - | PE(32:0) | 25OH-Chol | 24.0 | BCD100427B028 | 14.7 | pmol/sample |